【摘要】 本文根据多个国家(地区)对罕见病和罕用药的界定和制定激励措施进行比较,通过分析罕见病和罕用药的现状来了解这些激励措施对罕用药选定的积极作用,探讨我国制定罕用药相关政策的思路。更多还原

【Abstract】 Based on the comparison of the definitions and the incentive measures for both rare diseases and orphan drugs in several countries and regions,their current situation was analyzed so as to learn the positive effects of these incentive measures on the designation of orphan drugs.Suggestions were proposed to explore the policies on the development of orphan drugs in China.更多还原